Filing Details
- Accession Number:
- 0001104659-12-043636
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-14 18:11:00
- Reporting Period:
- 2012-06-12
- Filing Date:
- 2012-06-14
- Accepted Time:
- 2012-06-14 17:11:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236514 | Patrick Michael Miller | 1172 Castro Street Mountain View CA 94040 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-06-12 | 25,000 | $10.19 | 32,943 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-06-12 | 25,000 | $25.00 | 7,943 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-06-12 | 25,000 | $0.00 | 25,000 | $10.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 375,000 | 2020-04-30 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2012.
- Includes 2,188 shares acquired on May 14, 2012 under the VIVUS, Inc. Employee Stock Purchase Plan.
- Twenty-five percent (25%) of the total number of shares become exercisable on 4/26/11 and one forty-eighth (1/48th) of the total number of shares become exercisable over the next 36 months.
Billionaire Hedge Funds
